Abstract: In one aspect, the present invention features a method of producing a tablet including cetirizine including the steps of: (i) mixing cetirizine, a polyol, and a solvent for the cetirizine to form a cetirizine:polyol complex, wherein the solvent comprises water and an alkalizing agent and has a pH from about 2 to about 7; (ii) isolating particles of the cetirizine:polyol complex from the mixture; and (iii) forming the particles into a tablet.
Type:
Grant
Filed:
September 3, 2009
Date of Patent:
February 26, 2013
Assignee:
McNeil-PPC, Inc.
Inventors:
Kenneth Day, Kangping Xiao, Satish Kamath, Indu Shah
Abstract: The present invention provides an edible dosage form that incorporates optical elements (e.g., printed patterns, microrelief gratings, and/or macrorelief gratings), capable of producing unique optical effects and images in order to enable a user to better identify and differentiate the dosage forms, as well as to improve the detection of counterfeit production thereof, wherein the edible dosage forms may be made in a variety of ways to incorporate the optical elements therein.
Abstract: In one aspect, the present invention features a tablet including: (i) a first drug layer including naproxen; (ii) a second drug layer including a decongestant (e.g., pseudoephedrine) wherein said second drug layer is a sustained release layer adapted to deliver a therapeutically effective amount of pseudoephedrine for a period of at least twelve hours; and (iii) a barrier layer that does not include naproxen, wherein the barrier layer is in contact with the first drug layer; and (iv) a third drug layer including cetirizine, wherein the third drug layer is in contact with the barrier layer and is not in contact with the first drug layer.
Type:
Grant
Filed:
January 4, 2010
Date of Patent:
February 19, 2013
Assignee:
McNeil-PPC, Inc.
Inventors:
Satish Kamath, Indukumar G. Shah, Michael Nichols, Dinesh Patel
Abstract: A pharmaceutical composition for oral administration comprising a core and a film coating on the core that exhibits enhanced disintegration characteristics is disclosed. The film coating comprises a film forming polymer, an organic solvent, a super-disintegrant and, optionally, an acid labile material.
Type:
Grant
Filed:
October 28, 2010
Date of Patent:
February 5, 2013
Assignee:
McNeil-PPC, Inc.
Inventors:
Jen-Chi Chen, Frank J. Bunick, Gerard McNally
Abstract: The invention relates to methods of screening mixtures containing a pharmaceutical compound and an excipient to identify properties of the pharmaceutical compound/excipient combination that retard solid-state nucleation. The invention further relates to increasing the solubility, dissolution and bioavailability of a drug with low solubility in gastric fluids conditions by combining the drug with a precipitation retardant and an optional enhancer.
Type:
Grant
Filed:
December 24, 2003
Date of Patent:
January 29, 2013
Assignee:
McNeil-PPC, Inc.
Inventors:
Mark Tawa, Julius Remenar, Matthew L. Peterson, Örn Almarsson, Hector Guzman, Hongming Chen, Mark Oliveira
Abstract: Tampons are packaged in a substantially cylindrical wrapper formed of a flexible, sheet-like material that is closed with one or more attachment zones having one or more gaps crossed by a line of weakness. The wrapper is closed at both ends and has a longitudinal seam area in which overlapping portions of the flexible, sheet-like material are attached. The longitudinal seam area comprises a substantially longitudinal attachment zone with a first edge and a second edge that defines a seam area. The line of weakness has a first end disposed within the seam area at a distance from a first end of the wrapper package; extends through a gap in the substantially longitudinal attachment zone; continues generally circumferentially about the wrapper; and terminates at a second end disposed within the seam area at the second edge of the substantially longitudinal attachment zone. The line of weakness extends across the seam area, and the wrapper can be removed as a single piece.
Type:
Grant
Filed:
November 19, 2009
Date of Patent:
January 22, 2013
Assignees:
McNeil-PPC, Inc., Johnson & Johnson GmbH
Inventors:
Otto Handel, Stephan M. Linkel, Simone Weitz
Abstract: The present invention features a method of manufacturing a tablet containing a pharmaceutically active agent by the steps of: (a) adding a powder containing a pharmaceutically-acceptable carrier to a die cavity; (b) injecting a liquid drug composition containing the pharmaceutically active agent into the die cavity such that the liquid drug composition contacts the powder; (c) compressing the combination of the powder and the liquid drug composition within the die cavity to form the tablet; and (d) removing the tablet from the die cavity.
Type:
Grant
Filed:
December 17, 2008
Date of Patent:
January 22, 2013
Assignee:
McNeil-PPC, Inc.
Inventors:
Frank J. Bunick, Joseph Luber, Stephen A. Ulrich, David W. Wynn
Abstract: The present invention is directed to an apparatus that includes a microcurrent delivery device portion and at least one independent sensory cue delivery means. The independent sensory cue delivery means can provide an independent sensory cue selected from the group consisting of vibration, heat, cool, skin irritation, tingling, fragrance or auditory.
Type:
Application
Filed:
September 12, 2012
Publication date:
January 10, 2013
Applicant:
MCNEIL-PPC,INC.
Inventors:
Leo B. Kriksunov, Aliya Z. Omer, Edward Roche, Joshua Ghaim, Naomi Furgiule
Abstract: The present invention features a process for making a lozenge product including the steps of forming a powder blend containing an amorphous carbohydrate polymer into the desired shape of the lozenge product and applying radiofrequency energy to the shape for a sufficient period of time to soften or melt said amorphous carbohydrate polymer to fuse the shape into said lozenge product.
Type:
Grant
Filed:
September 22, 2010
Date of Patent:
January 1, 2013
Assignee:
McNeil-PPC, Inc.
Inventors:
Jen-Chi Chen, Harry S. Sowden, Joseph R. Luber, Leo B. Kriksunov, Frank J. Bunick, Christopher E. Szymczak, Gregory E. Koll
Abstract: A chewing gum comprising at least one active pharmaceutical ingredient (API) with a core onto which is applied at least one inner polymer film coating and thereafter onto which is applied at least one outer hard coating. A preferred API is nicotine. Flavoring agents may be incorporated in the core, in the at least one inner polymer film coating and/or in the at least one outer hard coating. The gums formed exhibit a long lasting effect of flavoring agent(s) and result in the domination of flavoring agents in the coating(s) over flavoring agent(s) in the core, thereby (a) avoiding problems of chemical or pharmaceutical incompatibility between an API in the core and flavoring agent(s) in the coating(s) and (b) achieving an increased control of the release of the API and of non-active excipients.
Abstract: The present invention relates to a process for stabilizing phenylephrine including drying an acidic solution of phenylephrine and pharmaceutical compositions including stabilized phenylephrine.
Type:
Grant
Filed:
August 13, 2007
Date of Patent:
December 4, 2012
Assignee:
McNeil-PPC, Inc.
Inventors:
Hugh Huang, Jonathan Zeszotarski, Anthony Bean, William Michael Nichols
Abstract: This present invention relates to a process for winding tape to prevent or reduce telescoping of the tape (e.g., dental tape) as it is wound onto a bobbin spool. Dispensers comprising such bobbins are also discussed herein.
Abstract: An absorbent article including a cover layer, a barrier layer and an absorbent system arranged between the cover layer and the barrier layer, the absorbent article being drapeable and possessing the absorbency attributes required of a sanitary napkin.
Abstract: The present invention regards methods and devices for detecting plaque on a surface in the oral cavity to which a fluorescent agent capable of binding to plaque has been applied, whereby a radiation source emits incident radiation for contacting the surface, reflected light and fluorescent emission resulting from contact of the radiation with the surface is collected by an optical collector and conveyed by an optical pathway in the device, where the optical light signal of the reflected light and fluorescent emission is converted to an electrical signal, and where the electrical signals of the fluorescent emission and the reflected light are then mathematically manipulated to provide a compensated plaque value as a function of the distance from the optical collector and the surface of the oral cavity to which the fluorescent agent has been applied.